Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression

Scientifica

Volumn 2016, Issue , 2016, Pages

  Paudel, Keshav Raj ^a   Panth, Nisha ^a   Kim, Dong Wook ^a  

^a Mokpo National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84975293231     PISSN: None     EISSN: 2090908X     Source Type: Journal    
DOI: 10.1155/2016/8514056     Document Type: Review

References (86)

1. M. J. VanWijk, E. VanBavel, A. Sturk, and R. Nieuwland, "Microparticles in cardiovascular diseases," Cardiovascular Research, vol. 59, no. 2, pp. 277-287, 2003.
2. C. N. Franca, M. C. de Oliveira Izar, J. B. do Amaral, D. M. Tegani, and F. A. H. Fonseca, "Microparticles as potential biomarkers of cardiovascular disease," Arquivos Brasileiros de Cardiologia, vol. 104, no. 2, pp. 169-174, 2015.
3. A. Angelillo-Scherrer, "Leukocyte-derived microparticles in vascular homeostasis," Circulation Research, vol. 110, no. 2, pp. 356-369, 2012.
4. S. Patz, C. Trattnig, G. Grünbacher et al., "More than cell dust: microparticles isolated fromcerebrospinal fluid of brain injured patients are messengers carrying mRNAs, miRNAs, and proteins," Journal of Neurotrauma, vol. 30, no. 14, pp. 1232-1242, 2013.
5. G. Pasterkamp and D. de Kleijn, "Microparticles, debris that hurts," Journal of theAmericanCollege of Cardiology, vol. 52, no. 16, pp. 1312-1313, 2008.
6. D. E. Connor,T.Exner,D.D.F.Ma, andJ.E. Joseph, "Themajority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib," Thrombosis and Haemostasis, vol. 103, no. 5, pp. 1044-1052, 2010.
7. M. Sekula, G. Janawa, E. Stankiewicz, and E. Stepień, "Endothelial microparticle formation in moderate concentrations of homocysteine and methionine in vitro," Cellular and Molecular Biology Letters, vol. 16, no. 1, pp. 69-78, 2011.
8. M. G.Macey, N. Enniks, and S. Bevan, "Flow cytometric analysis of microparticle phenotype and their role in thrombin generation," Cytometry Part B: Clinical Cytometry, vol. 80, no. 1, pp. 57-63, 2011.
9. N. Amabile, A. P. Guérin, A. Leroyer et al., "Circulating endothelial microparticles are associatedwith vascular dysfunction in patients with end-stage renal failure," Journal of the American Society of Nephrology, vol. 16, no. 11, pp. 3381-3388, 2005.
10. A. F. Tramontano, R. Lyubarova, J. Tsiakos, T. Palaia, J. R. Deleon, and L. Ragolia, "Circulating endothelial microparticles in diabetes mellitus," Mediators of Inflammation, vol. 2010, Article ID 250476, 8 pages, 2010.
11. C.-C. Wang, C.-C. Tseng, C.-C. Hsiao et al., "Circulating endothelial-derived activated microparticle: a useful biomarker for predicting one-year mortality in patients with advanced non-small cell lung cancer," BioMed Research International, vol. 2014, Article ID173401, 11 pages, 2014.
12. C.-C. Tseng, C.-C. Wang, H.-C. Chang et al., "Levels of circulating microparticles in lung cancer patients and possible prognostic value," Disease Markers, vol. 35, no. 5, pp. 301-310, 2013.
13. S. M. Schindler, J. P. Little, and A. Klegeris, "Microparticles: a new perspective in central nervous system disorders," BioMed Research International, vol. 2014, Article ID 756327, 17 pages, 2014.
14. D. M. Babbitt, K. M. Diaz, D. L. Feairheller et al., "Endothelial activation microparticles and inflammation status improvewith exercise training inAfrican Americans," International Journal of Hypertension, vol. 2013, Article ID 538017, 8 pages, 2013.
15. R. V. Vince, B. Chrismas, A. W. Midgley, L. R. McNaughton, and L. A. Madden, "Hypoxia mediated release of endothelial microparticles and increased association of S100A12 with circulating neutrophils," Oxidative Medicine and Cellular Longevity, vol. 2, no. 1, pp. 2-6, 2009.
16. J. Perez-Hernandez and R. Cortes, "Extracellular vesicles as biomarkers of systemic lupus erythematosus," Disease Markers, vol. 2015, Article ID 613536, 7 pages, 2015.
17. A. Celi, R. Lorenzet, B. C. Furie, and B. Furie, "Microparticles and a P-selectin-mediated pathway of blood coagulation," Disease Markers, vol. 20, no. 6, pp. 347-352, 2004.
18. S. F. Mause and C. Weber, "Microparticles: protagonists of a novel communication network for intercellular information exchange," Circulation Research, vol. 107, no. 9, pp. 1047-1057, 2010.
19. B. Toth, S. Liebhardt, K. Steinig et al., "Platelet-derived microparticles and coagulation activation in breast cancer patients,"Thrombosis and Haemostasis, vol. 100, no. 4, pp. 663-669, 2008.
20. M. S.Williams, H. L. Rogers, N.-Y.Wang, and R. C. Ziegelstein, "Do platelet-derived microparticles play a role in depression, inflammation, and acute coronary syndrome?" Psychosomatics, vol. 55, no. 3, pp. 252-260, 2014.
21. S. Mezouar, D. Mege, R. Darbousset et al., "Involvement of platelet-derived microparticles in tumor progression and thrombosis," Seminars in Oncology, vol. 41, no. 3, pp. 346-358, 2014.
22. V. Faure, L. Dou, F. Sabatier et al., "Elevation of circulating endothelial microparticles in patients with chronic renal failure," Journal of Thrombosis and Haemostasis, vol. 4, no. 3, pp. 566-573, 2006.
23. S. Tual-Chalot, F. Gagnadoux, W. Trzepizur, P. Priou, R. Andriantsitohaina, andM. C.Martinez, "Circulating microparticles from obstructive sleep apnea syndrome patients induce endothelin-mediated angiogenesis," Biochimica et Biophysica Acta, vol. 1842, no. 2, pp. 202-207, 2014.
24. F. Cheng, Y. Wang, J. Li et al., "Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans," International Journal of Cardiology, vol. 167, no. 3, pp. 936-942, 2013.
25. B.Wen, V. Combes, A. Bonhoure, B. B.Weksler, P.-O. Couraud, and G. E. R. Grau, "Endotoxin-induced monocytic microparticles have contrasting effects on endothelial inflammatory responses," PLoS ONE, vol. 9, no. 3,Article ID e91597, 2014.
26. R. Nieuwland, R. J. Berckmans, S. McGregor et al., "Cellular origin and procoagulant properties of microparticles in meningococcal sepsis," Blood, vol. 95, no. 3, pp. 930-935, 2000.
27. F. F. Hoyer, M. K. Giesen, C. Nunes Franc,a, D. Lütjohann, G. Nickenig, and N. Werner, "Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice," Journal of Cellular and Molecular Medicine, vol. 16, no. 11, pp. 2777-2788, 2012.
28. O. P. Barry, M. G. Kazanietz, D. Praticò, and G. A. FitzGerald, "Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway," Journal of Biological Chemistry, vol. 274, no. 11, pp. 7545-7556, 1999.
29. O. P. Barry, D. Praticò, J. A. Lawson, and G. A. FitzGerald, "Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles," Journal of Clinical Investigation, vol. 99, no. 9, pp. 2118-2127, 1997.
30. O. P. Barry, D. Praticò, R. C. Savani, and G. A. FitzGerald, "Modulation of monocyte-endothelial cell interactions by platelet microparticles," Journal of Clinical Investigation, vol. 102, no. 1, pp. 136-144, 1998.
31. S. B. Forlow, R. P. McEver, and M. U. Nollert, "Leukocyteleukocyte interactions mediated by platelet microparticles under flow," Blood, vol. 95, no. 4, pp. 1317-1323, 2000.
32. W. Jy,W.-W.Mao, L. L.Horstman, J. Tao, and Y. S. Ahn, "Platelet microparticles bind, activate and aggregate neutrophils in vitro," Blood Cells, Molecules, and Diseases, vol. 21, no. 3, pp. 217-231, 1995.
33. J. J. Jimenez, W. Jy, L. M. Mauro, L. L. Horstman, C. Soderland, and Y. S. Ahn, "Endothelial microparticles released in thrombotic thrombocytopenic purpura express vonWillebrand factor and markers of endothelial activation," British Journal of Haematology, vol. 123, no. 5, pp. 896-902, 2003.
34. H.Koga, S. Sugiyama, K.Kugiyamaet al., "Elevated levels ofVEcadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease," Journal of the American College of Cardiology, vol. 45, no. 10, pp. 1622-1630, 2005.
35. B. Szotowski, S. Antoniak, P. Goldin-Lang et al., "Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation-and cytokine-induced endothelial cells," Cardiovascular Research, vol. 73, no. 4, pp. 806-812, 2007.
36. T. P. Lozito and R. S. Tuan, "Endothelial cell microparticles act as centers of matrix metalloproteinsase-2 (MMP-2) activation and vascularmatrix remodeling," Journal of Cellular Physiology, vol. 227, no. 2, pp. 534-549, 2012.
37. A. M. Curtis, P. F. Wilkinson, M. Gui, T. L. Gales, E. Hu, and J. M. Edelberg, "p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles," Journal ofThrombosis andHaemostasis, vol. 7, no.4,pp. 701-709, 2009.
38. Z.Mallat, H. Benamer, B. Hugel et al., "Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes," Circulation, vol. 101, no. 8, pp. 841-843, 2000.
39. J. J. Jimenez,W. Jy, L. M. Mauro, C. Soderland, L. L. Horstman, and Y. S. Ahn, "Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis," Thrombosis Research, vol. 109, no. 4, pp. 175-180, 2003.
40. J. Gauley and D. S. Pisetsky, "The release of microparticles by RAW 264.7 macrophage cells stimulated with TLR ligands," Journal of Leukocyte Biology, vol. 87, no. 6, pp. 1115-1123, 2010.
41. M. Li, D. Yu, K. Jon Williams, and M.-L. Liu, "Tobacco smoke induces the generation of procoagulant microvesicles from human monocytes/macrophages," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 9, pp. 1818-1824, 2010.
42. J.-G. Wang, J. C. Williams, B. K. Davis et al., "Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner," Blood, vol. 118, no. 8, pp. 2366-2374, 2011.
43. E. Milbank, R. Soleti, E. Martinez et al., "Microparticles from apoptotic RAW 264.7 macrophage cells carry tumour necrosis factor-α functionally active on cardiomyocytes from adult mice," Journal of Extracellular Vesicles, vol. 4, article 28621, 2015.
44. C. Bardelli, A. Amoruso, D. Federici Canova et al., "Autocrine activation of human monocyte/macrophages by monocytederived microparticles and modulation by PPARγ ligands," British Journal of Pharmacology, vol. 165, no. 3, pp. 716-728, 2012.
45. C. M. Boulanger, A. Scoazec, T. Ebrahimian et al., "Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction," Circulation, vol. 104, no. 22, pp. 2649-2652, 2001.
46. Z.Mallat, B.Hugel, J.Ohan, G. Lesèche, J.-M. Freyssinet, and A. Tedgui, "Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity," Circulation, vol. 99, no. 3, pp. 348-353, 1999.
47. M.Hristov,W. Erl, S. Linder, and P. C.Weber, "Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro," Blood, vol. 104, no. 9, pp. 2761-2766, 2004.
48. F. Dignat-George and C. M. Boulanger, "The many faces of endothelial microparticles," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 1, pp. 27-33, 2011.
49. A.Mezentsev, R.M. H.Merks, E. O'Riordan et al., "Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress," American Journal of Physiology-Heart and Circulatory Physiology, vol. 289, no. 3, pp. H1106-H1114, 2005.
50. F. Bretelle, F. Sabatier, D. Desprez et al., "Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction,"Thrombosis andHaemostasis, vol. 89,no. 3, pp. 486-492, 2003.
51. R. A. Preston,W. Jy, J. J. Jimenez et al., "Effects of severe hypertension on endothelial and platelet microparticles," Hypertension, vol. 41, no. 2, pp. 211-217, 2003.
52. M. J. VanWijk, K. Boer, R. J. Berckmans et al., "Enhanced coagulation activation in preeclampsia: the role of APC resistance, microparticles and other plasma constituents," Thrombosis and Haemostasis, vol. 88, no. 3, pp. 415-420, 2002.
53. M. J. VanWijk, R. Nieuwland, K. Boer, J. A. M. Van Der Post, E. VanBavel, and A. Sturk, "Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction?" American Journal ofObstetrics&Gynecology, vol. 187, no. 2, pp. 450-456, 2002.
54. H.-H. Lee, K. R. Paudel, and D.-W. Kim, "Terminalia chebula fructus inhibits migration and proliferation of vascular smooth muscle cells and production of inflammatory mediators in RAW 264.7," Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 502182, 10 pages, 2015.
55. R. Karki, S.-B. Kim, and D.-W. Kim, "Magnolol inhibits migration of vascular smoothmuscle cells via cytoskeletal remodeling pathway to attenuate neointima formation," Experimental Cell Research, vol. 319, no. 20, pp. 3238-3250, 2013.
56. R. Karki, C.-H. Park, and D.-W. Kim, "Extract of buckwheat sprouts scavenges oxidation and inhibits pro-inflammatory mediators in lipopolysaccharide-stimulated macrophages (RAW264.7)," Journal of Chinese Integrative Medicine, vol. 11, no. 4, pp. 246-252, 2013.
57. R.Karki,N. Sahi, E.-R. Jeon,Y.-S. Park, andD.-W.Kim, "Chungtaejeon, a Korean fermented tea, scavenges oxidation and inhibits cytokine induced proliferation and migration of human aortic smooth muscle cells," Plant Foods for Human Nutrition, vol. 66, no. 1, pp. 27-33, 2011.
58. R. Karki, E.-R. Jeon, and D.-W. Kim, "Nelumbo nucifera leaf extract inhibits neointimal hyperplasia through modulation of smooth muscle cell proliferation and migration," Nutrition, vol. 29, no. 1, pp. 268-275, 2013.
59. R. Karki, O.-M. Ho, and D.-W. Kim, "Magnolol attenuates neointima formation by inducing cell cycle arrest via inhibition of ERK1/2 and NF-κB activation in vascular smooth muscle cells," Biochimica et Biophysica Acta, vol. 1830, no. 3, pp. 2619-2628, 2013.
60. G. Taraboletti, S. D'Ascenzo, P. Borsotti, R. Giavazzi, A. Pavan, and V. Dolo, "Shedding of the matrix metalloproteinasesMMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells," The American Journal of Pathology, vol. 160, no. 2, pp. 673-680, 2002.
61. H. C. Anderson, "Matrix vesicles and calcification," Current Rheumatology Reports, vol. 5, no. 3, pp. 222-226, 2003.
62. R. Lacroix, F. Sabatier, A.Mialhe et al., "Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism thatmodulates angiogenic properties of endothelial progenitor cells in vitro," Blood, vol. 110, no. 7, pp. 2432-2439, 2007.
63. O. Morel, N. Morel, B. Hugel et al., "The significance of circulating microparticles in physiology, inflamatory and thrombotic diseases," La Revue deMédecine Interne, vol. 26, no. 10, pp. 791-801, 2005 (French).
64. A. H. M.Moons, M. Levi, and R. J. G. Peters, "Tissue factor and coronary artery disease," Cardiovascular Research, vol. 53, no. 2, pp. 313-325, 2002.
65. J. Steffel, M. Hermann, H. Greutert et al., "Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation," Circulation, vol. 111, no. 13, pp. 1685-1689, 2005.
66. E. Napoleone, A. Di Santo, and R. Lorenzet, "Monocytes upregulate endothelial cell expression of tissue factor: a role for cellcell contact and cross-talk," Blood, vol. 89, no. 2, pp. 541-549, 1997.
67. M.Mesri and D. C. Altieri, "Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway," Journal of Biological Chemistry, vol. 274, no. 33, pp. 23111-23118, 1999.
68. A. Tesse, M. C.Martínez, B.Hugel et al., "Upregulation of proinflammatory proteins through NF-κB pathway by shed membrane microparticles results in vascular hyporeactivity," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 12, pp. 2522-2527, 2005.
69. A. Scanu, N. Molnarfi, K. J. Brandt, L. Gruaz, J.-M. Dayer, and D. Burger, "Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro-and anti-inflammatory cytokine production by high-density lipoproteins," Journal of Leukocyte Biology, vol. 83, no. 4, pp. 921-927, 2008.
70. M. H. Gräler and E. J. Goetzl, "Lysophospholipids and their G protein-coupled receptors in inflammation and immunity," Biochimica et Biophysica Acta, vol. 1582, no. 1-3, pp. 168-174, 2002.
71. A. S. Leroyer, F. Anfosso, R. Lacroix et al., "Endothelialderived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis," Thrombosis and Haemostasis, vol. 104, no. 3, pp. 456-463, 2010.
72. S. Simoncini, M.-S. Njock, S. Robert et al., "Trail/Apo2L mediates the release of procoagulant endothelial microparticles induced by thrombin in vitro: a potential mechanism linking inflammation and coagulation," Circulation Research, vol. 104, no. 8, pp. 943-951, 2009.
73. F. Meziani, A. Tesse, E. David et al., "Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility," The American Journal of Pathology, vol. 169, no. 4, pp. 1473-1483, 2006.
74. M. Mesri and D. C. Altieri, "Endothelial cell activation by leukocyte microparticles," Journal of Immunology, vol. 161, no. 8, pp. 4382-4387, 1998.
75. S. H. van Ierssel, E. M. van Craenenbroeck, V. M. Conraads et al., "Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied," Thrombosis Research, vol. 125, no. 4, pp. 332-339, 2010.
76. P. J. A. Yong, C. H. Koh, and W. S. N. Shim, "Endothelial microparticles: missing link in endothelial dysfunction?" European Journal of Preventive Cardiology, vol. 20,no. 3, pp.496-512, 2013.
77. R. Soleti, T. Benameur, C. Porro, M. A. Panaro, R. Andriantsitohaina, and M. C. Martínez, "Microparticles harboring Sonic Hedgehog promote angiogenesis through the upregulation of adhesion proteins and proangiogenic factors," Carcinogenesis, vol. 30, no. 4, pp. 580-588, 2009.
78. P. E.Rautou, A. S. Leroyer, B. Ramkhelawon et al., "Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration," Circulation Research, vol. 108, no. 3, pp. 335-343, 2011.
79. K. D. O'Brien, T. O.McDonald, A. Chait, M. D. Allen, and C. E. Alpers, "Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content," Circulation, vol. 93, no. 4, pp. 672-682, 1996.
80. R. Virmani, F. D. Kolodgie, A. P. Burke et al., "Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage," Arteriosclerosis,Thrombosis, and Vascular Biology, vol. 25, no. 10, pp. 2054-2061, 2005.
81. P. R. Moreno, K.-R. Purushothaman, M. Sirol, A. P. Levy, and V. Fuster, "Neovascularization in human atherosclerosis," Circulation, vol. 113, no. 18, pp. 2245-2252, 2006.
82. M. Jayachandran, R. D. Litwiller, W. G. Owen, andV. M. Miller, "Circulating microparticles and endogenous estrogen in newly menopausal women," Climacteric, vol. 12, no. 2, pp. 177-184, 2009.
83. N. Figueroa-Vega, C. Moreno-Frías, and J. M. Malacara, "Alterations in adhesion molecules, pro-inflammatory cytokines and cell-derived microparticles contribute to intima-media thickness and symptoms in postmenopausalwomen," PLoSONE, vol. 10, no. 5,Article ID e0120990, 2015.
84. M. Jayachandran, R. D. Litwiller, B. D. Lahr et al., "Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk," Journal of Cardiovascular Translational Research, vol. 4, no. 6, pp. 811-822, 2011.
85. M.-V. Noci, R. Ramírez, M. Lluch, M. Rodríguez, and J. Carracedo, "Changes in endothelial microparticles and endothelial progenitor cells in obese patients in response to surgical stress," The Journal of Bone & Joint Surgery - American Volume, vol. 97, no. 5, pp. 353-358, 2015.
86. L. F. Heinrich, D. K. Andersen, M. E. Cleasby, and C. Lawson, "Long-termhigh fat feeding of rats results in increased numbers of circulating microvesicles with pro-inflammatory effects on endothelial cells," British Journal of Nutrition, vol. 113, no. 11, pp. 1704-1711, 2015.